glp-1 drugs risks GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment GLP-1 Drugs Use, Risks, and
Description
Katren S
Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Shapely is in-network with Humana for weight loss treatment
Once weekly subcutaneous injection, gradually titrated by your provider
Mercedez Hernandez walks through what patients should consider when weighing their options.
Our vision is a world free of MS.
